within Pharmacolibrary.Drugs.R_RespiratorySystem.R03A_AdrenergicsInhalants.R03AL06_OlodaterolAndTiotropiumBromide;

model OlodaterolAndTiotropiumBromide
  extends Pharmacolibrary.Drugs.ATC.R.R03AL06;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>R03AL06</td></tr><td>route:</td><td>inhalation</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Olodaterol and tiotropium bromide is a fixed-dose combination inhalation therapy used as a long-acting bronchodilator for maintenance treatment of chronic obstructive pulmonary disease (COPD). Olodaterol is a long-acting beta2-adrenergic agonist (LABA), and tiotropium bromide is a long-acting muscarinic antagonist (LAMA). The combination is approved and widely prescribed for adults with COPD to improve lung function and reduce symptoms.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters based on published healthy adult and COPD subject studies with fixed-dose inhalation of olodaterol/tiotropium bromide combination (equivalent to 5 mcg olodaterol and 5 mcg tiotropium bromide daily).</p><h4>References</h4><ol><li><p>Wang, Z, et al., &amp; Luo, Z (2020). Pharmacokinetics and safety of tiotropium+olodaterol 5 μg/5 μg fixed-dose combination in Chinese patients with COPD. <i>Pulmonary pharmacology &amp; therapeutics</i> 63 101944–None. DOI:<a href=\"https://doi.org/10.1016/j.pupt.2020.101944\">10.1016/j.pupt.2020.101944</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32916296/\">https://pubmed.ncbi.nlm.nih.gov/32916296</a></p></li><li><p>Dhillon, S (2016). Tiotropium/Olodaterol: A Review in COPD. <i>Drugs</i> 76(1) 135–146. DOI:<a href=\"https://doi.org/10.1007/s40265-015-0527-2\">10.1007/s40265-015-0527-2</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26683033/\">https://pubmed.ncbi.nlm.nih.gov/26683033</a></p></li><li><p>Melani, AS (2018). Olodaterol for the treatment of chronic obstructive pulmonary disease: a narrative review. <i>Expert opinion on pharmacotherapy</i> 19(14) 1603–1611. DOI:<a href=\"https://doi.org/10.1080/14656566.2018.1518431\">10.1080/14656566.2018.1518431</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30311516/\">https://pubmed.ncbi.nlm.nih.gov/30311516</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end OlodaterolAndTiotropiumBromide;
